SB189 expands Hawaii’s mandated health insurance coverage for breast cancer screening. The bill keeps the existing requirement that most health plans cover annual low-dose mammography for patients age 40 and older, and it updates the language to refer to “patients” rather than only women. For patients of any age who are at above-average risk for breast cancer, the bill changes the coverage standard from a physician-recommended mammogram to any supplemental imaging deemed medically necessary by the patient’s primary care provider.
The bill also adds a new coverage mandate for supplemental breast imaging for any patient, regardless of age, when medically necessary and ordered by the primary care provider. Covered services include breast MRI, ultrasound, and digital breast tomosynthesis. The bill retains existing provisions on cost-sharing, allowing coinsurance but requiring deductibles, copayments, and dollar limits to be at least as favorable as those for other radiological exams. It also preserves the insurer option to provide services through approved provider contracts.
In addition to the breast cancer screening changes, the bill makes conforming updates to the broader insurance statute governing coverage for specific services, and it renames the mammography section to “Breast cancer screening.” The measure is framed as a public health and mortality-reduction effort, and the legislature cites a prior auditor study on a nearly identical proposal as support for the mandate’s social and financial impacts. The bill is set to take effect on December 31, 2050, which is far in the future and appears to function as a delayed effective date.
The overall sentiment in the available legislative history appears favorable. The Senate Health and Human Services Committee passed the bill with amendments by a 4-0 vote, indicating unanimous support among those voting at that stage. No committee transcript is available, so there is no recorded floor discussion or detailed testimony in the provided materials.
The main point of potential contention is the insurance mandate itself, especially the expansion to supplemental imaging for all patients and the requirement that insurers cover medically necessary imaging determined by a primary care provider. Such mandates can raise concerns about premium impacts, utilization, and medical necessity standards, although the bill’s findings suggest the legislature views those concerns as previously studied and manageable. Another possible issue is the delayed effective date, which may reflect policy timing or implementation considerations rather than disagreement over the substance.
Impact
SB189 amends Hawaii Revised Statutes sections 431:10A-116 and 432:1-605 to expand mandatory health insurance coverage for breast cancer screening. It requires coverage for low-dose mammography for patients age 40 and older and broadens coverage for higher-risk patients and, separately, for any patient needing supplemental imaging such as MRI, ultrasound, or digital breast tomosynthesis when deemed medically necessary by a primary care provider. The bill also updates statutory terminology from gender-specific references to patient-based language and makes conforming changes to the insurance code.
Sentiment
The available voting record shows strong support: the Senate Health and Human Services Committee passed SB189 with amendments on a 4-0 vote. The bill’s stated purpose is to reduce breast cancer incidence and deaths through earlier screening, and the legislative findings reference a prior auditor study supporting the mandate’s social and financial impacts. No opposing testimony or recorded debate is provided in the materials, so the overall sentiment appears positive and policy-driven.
Contention
The likely areas of contention are the scope and cost of the insurance mandate, particularly the requirement that plans cover supplemental imaging for any patient when medically necessary and the use of primary care provider judgment to trigger coverage. Insurers or cost-conscious stakeholders may be concerned about premium increases, utilization growth, and how medical necessity will be applied. The bill’s supporters appear to prioritize early detection and risk-based screening access, while any opposition would likely focus on affordability and mandate expansion rather than the goal of breast cancer detection itself.